Families and friends who have a loved one living with dementia are being urged to consider the unexpected financial risks that can come with the disease.
With the isolation of lockdown causing a decline in 82 per cent of dementia sufferers, according to The Alzheimer s Society, investment platform, Hargreaves Lansdown, has pinpointed seven financial issues dementia sufferers can fall foul of.
Paying bills multiple times, falling victims to scams and spending unnecessarily are among the financial risks associated with dementia.
According to the Alzheimer’s Society, lockdown caused a decline in 82 per cent of dementia sufferers, as a result of seeing fewer visitors.
The merger has been approved by Astra and Alexion’s shareholders, and US competition authorities.
It was not clear yesterday whether the CMA had homed in on any particular issue. It would not comment on the probe.
However, in a sign of confidence, Astra said the deal is still expected to complete in September.
Soriot has pitched the takeover as a way for his firm to gain a foothold in lucrative treatments for rare diseases, particularly those caused by problems in the immune system, which Alexion specialises in.
Boston-based Alexion is already known for its flagship blood disease drug Soliris and has followed this up with Ultomiris, which was approved two years ago and has seen sales rocket.
This week, accountant EY said staff will work from home for two days a week for good. Rival BDO went further, telling staff to stay at home forever if they wish.
Only investment banks have put their foot down, with Goldman Sachs and JP Morgan telling staff to come in. Charles Hall, analyst at Peel Hunt, said: ‘The current situation is pretty unhelpful. More unemployment in the UK is also a worry for Greencore.’
Stock Watch - Ted Baker
Struggling British fashion group Ted Baker has managed to secure a new financing deal with its banks.
Sales have plunged during the pandemic, necessitating a turnaround plan.